NO167661C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,3-disubstituerte indoliner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,3-disubstituerte indoliner.

Info

Publication number
NO167661C
NO167661C NO871492A NO871492A NO167661C NO 167661 C NO167661 C NO 167661C NO 871492 A NO871492 A NO 871492A NO 871492 A NO871492 A NO 871492A NO 167661 C NO167661 C NO 167661C
Authority
NO
Norway
Prior art keywords
alkyl
indolines
pyridyl
chem
independently
Prior art date
Application number
NO871492A
Other languages
English (en)
Norwegian (no)
Other versions
NO871492D0 (no
NO167661B (no
NO871492L (no
Inventor
Melvyn John Myers
Victor Johannes Nickolson
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO871492D0 publication Critical patent/NO871492D0/no
Publication of NO871492L publication Critical patent/NO871492L/no
Publication of NO167661B publication Critical patent/NO167661B/no
Publication of NO167661C publication Critical patent/NO167661C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO871492A 1986-04-10 1987-04-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,3-disubstituerte indoliner. NO167661C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85001586A 1986-04-10 1986-04-10
US06/944,953 US4760083A (en) 1986-04-10 1987-01-05 3,3-disubstituted indolines

Publications (4)

Publication Number Publication Date
NO871492D0 NO871492D0 (no) 1987-04-09
NO871492L NO871492L (no) 1987-10-12
NO167661B NO167661B (no) 1991-08-19
NO167661C true NO167661C (no) 1991-11-27

Family

ID=27126891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871492A NO167661C (no) 1986-04-10 1987-04-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,3-disubstituerte indoliner.

Country Status (18)

Country Link
US (1) US4760083A (de)
EP (1) EP0241006B1 (de)
JP (1) JPH068293B2 (de)
KR (1) KR960007528B1 (de)
AT (1) ATE50572T1 (de)
AU (1) AU599370B2 (de)
CA (1) CA1301151C (de)
DE (1) DE3761768D1 (de)
DK (1) DK170164B1 (de)
ES (1) ES2054627T3 (de)
FI (1) FI89482C (de)
GR (1) GR3000359T3 (de)
HU (1) HU196792B (de)
IE (1) IE59680B1 (de)
MX (1) MX173308B (de)
NO (1) NO167661C (de)
NZ (1) NZ219928A (de)
PT (1) PT84651B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4806651A (en) * 1987-10-07 1989-02-21 E. I. Du Pont De Nemours And Company Process for preparing 3,3-disubstituted indolines
US4965066A (en) * 1989-06-06 1990-10-23 E. I. Du Pont De Nemours And Company Intranasal administration of 3,3-disubstituted indolines
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5260452A (en) * 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5087628A (en) * 1990-01-12 1992-02-11 Du Pont Merck Pharmaceutical Company 4,4'-[9H-fluoren-9-ylidenebis (methylene)]bispyrimidine for treating neurological disorders
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278045A (en) * 1990-02-28 1994-01-11 Du Pont Merck Pharmaceutical Company Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function
US5171745A (en) * 1990-07-13 1992-12-15 Du Pont Merck Pharmaceutical Company Method of treating neurological dysfunction using neutrotransmitter enhancers
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
CA2128233A1 (en) * 1992-01-16 1993-07-22 Wendell Wilkie Wilkerson Novel neurotransmitter releasers useful for cognition enhancement
US5698559A (en) * 1992-01-16 1997-12-16 The Dupont Merck Pharmaceutical Company Disubstituted polycyclic systems as cognition enhancers
AU4027693A (en) * 1992-04-16 1993-11-18 Du Pont Merck Pharmaceutical Company, The Substituted nitrogen containing spiro compounds for use in treating cognitive deficits
US5278162A (en) * 1992-09-18 1994-01-11 The Du Pont Merck Pharmaceutical Company 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
EP0664810A1 (de) * 1992-10-13 1995-08-02 The Du Pont Merck Pharmaceutical Company 3,3-substituierte tri- und tetracyclische ludolin-2-one zur behandlung von kognitiven störungen
TW281669B (de) * 1993-02-17 1996-07-21 Chugai Pharmaceutical Co Ltd
US5594001A (en) * 1993-04-08 1997-01-14 The Dupont Merck Pharmaceutical Company Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
HUT74104A (en) * 1993-04-08 1996-11-28 Du Pont Merck Pharma Novel polycyclic derivatives and pharmaceutical compositions containing them
US5308851A (en) * 1993-06-03 1994-05-03 The Du Pont Merck Pharmaceutical Company Bispyridyl-containing heterocycles useful for treating cognitive disorders
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CA2188427C (en) * 1994-04-29 2000-06-27 Robert A. Volkmann Neurotransmitter release enhancers
US5948781A (en) * 1997-05-27 1999-09-07 Pfizer Inc Adamantyl substituted oxindoles as pharmaceutical agents
US6262081B1 (en) * 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
DE60006145T2 (de) 1999-07-30 2004-06-09 Zenyaku Kogyo K.K. Azaindolizinon-derivate und agenzien zur verbesserung der kognitiver fähigkeiten,die dieselben als aktive inhaltstoffe enthalten
FR2804115B1 (fr) * 2000-01-25 2002-03-08 Sanofi Synthelabo Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
CN108658834B (zh) * 2017-03-31 2021-03-23 烟台药物研究所 一种吲哚酮衍生物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
ES426436A1 (es) * 1974-05-18 1976-07-01 Andreu Sa Dr Procedimiento para la obtencion de derivados de la 3,3-bis (4-hidroxifenil)-2-indolinona.
US4273860A (en) * 1977-12-28 1981-06-16 Eastman Kodak Company Inhibition of image formation utilizing cobalt(III) complexes
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
JPS55129284A (en) * 1979-03-27 1980-10-06 Shionogi & Co Ltd 3-(1-imipazolyl)indolin-2-one
US4372960A (en) * 1980-12-12 1983-02-08 Warner-Lambert Company Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
US4452990A (en) * 1982-11-15 1984-06-05 Warner-Lambert Company 1-Aroyl-5-oxo-2-pyrrolidinepropanoic acids and related esters
US4434169A (en) * 1983-01-03 1984-02-28 Warner-Lambert Company Pharmaceutical compositions and methods

Also Published As

Publication number Publication date
JPH068293B2 (ja) 1994-02-02
DK182087A (da) 1987-10-11
NO871492D0 (no) 1987-04-09
EP0241006A2 (de) 1987-10-14
FI871556A0 (fi) 1987-04-09
KR960007528B1 (ko) 1996-06-05
ATE50572T1 (de) 1990-03-15
IE59680B1 (en) 1994-03-23
DE3761768D1 (de) 1990-04-05
AU7133487A (en) 1987-10-15
FI89482B (fi) 1993-06-30
FI89482C (fi) 1993-10-11
EP0241006A3 (en) 1988-08-10
HUT44028A (en) 1988-01-28
JPS62277381A (ja) 1987-12-02
US4760083A (en) 1988-07-26
ES2054627T3 (es) 1994-08-16
KR870009996A (ko) 1987-11-30
FI871556A7 (fi) 1987-10-11
EP0241006B1 (de) 1990-02-28
MX173308B (es) 1994-02-15
IE870921L (en) 1987-10-10
PT84651A (en) 1987-05-01
DK182087D0 (da) 1987-04-09
AU599370B2 (en) 1990-07-19
DK170164B1 (da) 1995-06-06
GR3000359T3 (en) 1991-06-07
NO167661B (no) 1991-08-19
NZ219928A (en) 1989-08-29
NO871492L (no) 1987-10-12
CA1301151C (en) 1992-05-19
HU196792B (en) 1989-01-30
PT84651B (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
NO167661C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,3-disubstituerte indoliner.
DK586588D0 (da) Terapeutiske heterocycliske forbindelser
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
NO178067C (no) Analogifremgangsmåte til fremstilling av terapautisk aktive heterocykliske forbindelser
NO900542D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzokondenserte n-holdige heterocykliske derivater.
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
GB1353370A (en) Imidazolpyridine derivatives
BG105855A (en) 2-aminopyridines containing fused ring substituents
NO174712C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive heterocykliske forbindelser
EP0316456A4 (de) Ester-substituierte thienotriazoldiazepin-verbindungen und deren verwendung als arzneimittel.
ATE97894T1 (de) Pharmakologisch-aktive alkylthiobenzimidazolderivate und verfahren zu deren herstellung.
NO165106C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater.
EA199800720A1 (ru) Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора
FI872752A0 (fi) Foerfarande foer framstaellning av tert.butyl-ergolinderivat.
DK0560231T3 (da) Pyrazolo(3,4-a)acridinderivater som smertestillende midler
UA40569C2 (uk) Похідні метилпіперазиназепіну, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001